Medical/Pharmaceuticals

Havas Health & You Strengthens Capabilities in Innovation and Customer Experience

Adds Network Chief Experience Officer Role and Co-Managing Directors of Innovation Engine, Havas NOW NEW YORK, April 14, 2021 /PRNewswire/ -- The last 12-18 months has dawned a new era in health, along with new expectations of companies across the health spectrum. Adding to the already fast-pace...

2021-04-14 21:35 1417

Everest Medicines Announces that the US FDA has Granted Licensing Partner Gilead Sciences, Inc. Accelerated Approval of Trodelvy® for the Treatment of Metastatic Urothelial Cancer

SHANGHAI, April 14, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater ...

2021-04-14 21:33 5921

Gannex Announces the First Cohort Dosed in a U.S. Clinical Study with THR-β Agonist ASC41

SHANGHAI, April 14, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces the dosing of the first cohort in the U.S. Phase I cli...

2021-04-14 20:00 2606

BioVaxys Announces Final Clinical trial results of HPV product from EU partner ProCare Health Iberia published by American Society for Colposcopy and Cervical Pathology

VANCOUVER, BC, April 14, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:LMNGF) ("BioVaxys"), the world leader in haptenized antigen vaccines for antiviral and cancers applications, is pleased to announce the results of a clinical study conducted by ProCare Health Iberia...

2021-04-14 20:00 6380

Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery

SINGAPORE, April 14, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, announced the approval by the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for MLC1501 in traumatic brain injury (TBI). Moleac is dedicated in finding, dev...

2021-04-14 19:15 1762

New Study Reveals That Stress Causes People's Minds to Wander Close to 60% of the Workday

Sleep, purpose and a daily mind training practice are significant contributors to focus and productivity. NEW YORK, April 14, 2021 /PRNewswire/ -- People report that their minds wander at work 37% of the time, and stress increases mind-wandering by 2-3 times, according toThe Mind at Work study b...

2021-04-14 00:54 1684

Molecular Matrix and GenScript Partner to Launch SARS-CoV-2 Neutralizing Antibody Testing Service for Public

PISCATAWAY, New Jersey and WEST SACRAMENTO, Calif., April 13, 2021 /PRNewswire/ --Molecular Matrix, Inc.  (MMI) and GenScript Biotech Corp . announced today that they have partnered to offer GenScript's SARS-CoV-2 neutralizing antibody t...

2021-04-13 19:30 1447

ILC Dover Defines the Future of Sterile Manufacturing with the soloPURE™ Flexible Aseptic Isolator

NEWARK, Del., April 13, 2021 /PRNewswire/ -- ILC Dover LP ("ILC Dover" or the "Company"), specializing in the innovative design and production of single-use flexible solutions for global pharmaceutical and biopharmaceutical processing, today introduced the soloPURE™ flexible aseptic isolator, a c...

2021-04-13 18:00 1975

Harbour BioMed Presents Novel Antibody for Cancer Immunotherapy at 2021 American Association for Cancer Research Annual Meeting

CAMBRIDGE, Mass., SUZHOU, China and ROTTERDAM, Netherlands, April 13, 2021 /PRNewswire/ -- Harbour BioMed ("HBM"; HKEX: 02142.HK), a global clinical-stage biopharmaceutical company, presents its newly discovered fully human anti-B7H7 monoclonal antibody at the American Association for Cancer Rese...

2021-04-13 14:55 3353

MGI COVID-19 Container Lab Put to Test, Safeguarding the World Figure Skating Championships

STOCKHOLM, April 13, 2021 /PRNewswire/ -- The weeklong ISU World Figure Skating Championships (the Championships), an Olympic qualification event, were held in Stockholm, Sweden in late March. The world's top figure skaters from around the world had travelled toSweden to compete for the title of w...

2021-04-13 14:32 1409

Psychobiotic PS128 improves mood and sleep quality in its first clinical study on anxiety and stress

TAIPEI, April 13, 2021 /PRNewswire/ -- Bened Biomedical's psychobiotic PS128 significantly improved insomnia, stress, and anxiety during a recent clinical trial. Participants were IT professionals under high levels of work-life stress. Psychobiotics are probiotics that yield specific mental healt...

2021-04-13 10:00 2458

Ascentage Pharma Releases Preclinical Data of Its Core Drug Candidates at AACR Annual Meeting 2021, with Results Signifying the Potential of Multiple Combination Therapies in Cancer

SUZHOU, China and ROCKVILLE, Md., April 13, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today presented the preclinical results of ...

2021-04-13 08:28 1947

Alphamab Oncology Presented Clinical Data of KN046 Combined with Nab-paclitaxel in the Treatment of mTNBC at AACR 2021

SUZHOU, China, April 13, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that data from phase Ib/II clinical study (clinical trial No.: KN046-203) of PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel for the treatment of patients with metastatic trip...

2021-04-13 08:15 4052

Antengene Presented Preclinical Data Demonstrating Potent Synergistic Effect of the Combination of ATG-010 (Selinexor) and ATG-008 (Onatasertib) for the Treatment of Triple-Hit DLBCL

SHANGHAI, China and GAITHERSBURG, U.S., April 13, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in h...

2021-04-13 08:00 2821

Innovent and Lilly Release Phase 3 Results of TYVYT® (Sintilimab Injection) as a Second-Line Treatment for Squamous Non-Small Cell Lung Cancer at AACR Annual Meeting 2021

SAN FRANCISCO and SUZHOU, China, April 13, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-04-13 08:00 4007

Varian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive Year

PALO ALTO, Calif., April 13, 2021 /PRNewswire/ -- Varian (NYSE: VAR) today announced it received the Best After-Sales Service Award for Radiotherapy Products in the 2020 Chinese Medical Devices Industry Data and After-Sales Service Survey for the fourth year in a row. Varian's Net Promoter Score ...

2021-04-13 04:15 2431

Hospital at Home Care Set to Make it Big in the United States with Strong Support from the Government

Adoption of HaH model surged eight-fold in less than six months with the availability of advanced remote monitoring and digital health solutions, finds Frost & Sullivan SANTA CLARA, Calif., April 13, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, Payment Reforms and Remote Care Deliver...

2021-04-13 00:30 1822

Seegene begins exporting its latest COVID-19 variant tests around the world to help contain spread of pandemic

* Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month SEOUL, South Korea, April 12, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a biotechnology company specializing in molecular diagnostics, announced today that it has secured an export ...

2021-04-12 20:53 6278

PharmAbcine presents the non-clinical data of PMC-309 at AACR 2021

DAEJEON, South Korea, April 12, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company presented an e-poster featuring the non-clinical data of PMC-309 at American Associatio...

2021-04-12 20:00 1302

OOOPDS - a surgical planning software received TFDA Class-II medical device certification developed by Taiwan Main Orthopaedic Biotechnology Co., Ltd.

TAICHUNG, Taiwan, April 12, 2021 /PRNewswire/ -- Taiwan Main Orthopaedic Biotechnology announced today (12) that their OOOPDS 3D medical image reconstruction and surgical planning medical software has received TFDA Class-II certification. OOOPDS is the most comprehensive 3D surgical planning sof...

2021-04-12 19:50 2122
1 ... 396397398399400401402 ... 576